Trypanosoma cruzi Virulence Factors for the Diagnosis of Chagas' Disease
- PMID: 31538468
- DOI: 10.1021/acsinfecdis.9b00269
Trypanosoma cruzi Virulence Factors for the Diagnosis of Chagas' Disease
Abstract
trans-Sialidase and cruzipain are important virulence factors from Trypanosoma cruzi, the etiological agent of Chagas disease, that have highly antigenic domains in their structure and were reported as potential tools for diagnosis of the illness. The aim of the present study is to assess the possibility of using cruzipain and the catalytic domain of trans-sialidase in a Surface Plasmon Resonance-based immunosensor for the diagnosis of chronic Chagas disease. Immunoassays carried out with canine sera verified that cruzipain allows the detection of anti-Trypanosoma cruzi antibodies whereas recombinant trans-sialidase did not yield specific detections, due to the high dilutions of serum used in the immunoassays that hinder the possibility to sense the specific low titer antibodies. The developed cruzipain-based biosensor, whose price per assay is comparable to a commercial enzyme-linked immunosorbent assay (ELISA), was successfully applied for the rapid quantification of specific antibodies against Trypanosoma cruzi in fresh human sera showing an excellent agreement with ELISA.
Keywords: Chagas’ disease; Surface Plasmon Resonance; Trypanosoma cruzi; cruzipain; diagnostics; trans-sialidase.
Similar articles
-
Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.Clin Diagn Lab Immunol. 2003 Sep;10(5):826-30. doi: 10.1128/cdli.10.5.826-830.2003. Clin Diagn Lab Immunol. 2003. PMID: 12965912 Free PMC article.
-
Diagnostic Applicability of Neutralizing Antibodies to Trypanosoma cruzi Trans-sialidase.Methods Mol Biol. 2019;1955:239-246. doi: 10.1007/978-1-4939-9148-8_18. Methods Mol Biol. 2019. PMID: 30868532
-
trans-Sialidase neutralizing antibody detection in Trypanosoma cruzi-infected domestic reservoirs.Clin Vaccine Immunol. 2011 Jun;18(6):984-9. doi: 10.1128/CVI.00535-10. Epub 2011 Apr 6. Clin Vaccine Immunol. 2011. PMID: 21471302 Free PMC article.
-
The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.Glycobiology. 2015 Nov;25(11):1142-9. doi: 10.1093/glycob/cwv057. Epub 2015 Jul 29. Glycobiology. 2015. PMID: 26224786 Review.
-
SAPA/trans-sialidase and cruzipain: two antigens from Trypanosoma cruzi contain immunodominant but enzymatically inactive domains.FASEB J. 1992 Nov;6(14):3259-64. FASEB J. 1992. PMID: 1426764 Review.
Cited by
-
Antiparasitic Behavior of Trifluoromethylated Pyrazole 2-Amino-1,3,4-thiadiazole Hybrids and Their Analogues: Synthesis and Structure-Activity Relationship.Front Pharmacol. 2020 Oct 7;11:591570. doi: 10.3389/fphar.2020.591570. eCollection 2020. Front Pharmacol. 2020. PMID: 33117181 Free PMC article.
-
Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis.Biomol Biomed. 2023 Dec 28;24(4):952-958. doi: 10.17305/bb.2023.9934. Biomol Biomed. 2023. PMID: 38153528 Free PMC article.
-
Synthesis and Antiprotozoal Profile of 3,4,5-Trisubstituted Isoxazoles.ChemistryOpen. 2021 Oct;10(10):931-938. doi: 10.1002/open.202100141. Epub 2021 Jul 30. ChemistryOpen. 2021. PMID: 34331350 Free PMC article.
-
New Biomarker in Chagas Disease: Extracellular Vesicles Isolated from Peripheral Blood in Chronic Chagas Disease Patients Modulate the Human Immune Response.J Immunol Res. 2021 Jan 11;2021:6650670. doi: 10.1155/2021/6650670. eCollection 2021. J Immunol Res. 2021. PMID: 33506056 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical